Cargando…
In vivo assessment of the drug interaction between sorafenib and paracetamol in rats
PURPOSE: Sorafenib is a multi-targeted tyrosine kinase inhibitor (TKI) used for the treatment of advanced renal cell carcinoma, hepatocellular carcinoma and radioactive iodine resistant thyroid carcinoma. Neoplastic diseases are the cause of pain, which may occur regardless of the stage of the disea...
Autores principales: | Karbownik, Agnieszka, Sobańska, Katarzyna, Grabowski, Tomasz, Stanisławiak-Rudowicz, Joanna, Wolc, Anna, Grześkowiak, Edmund, Szałek, Edyta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305075/ https://www.ncbi.nlm.nih.gov/pubmed/32394097 http://dx.doi.org/10.1007/s00280-020-04075-3 |
Ejemplares similares
-
Pharmacokinetic Drug Interaction Study of Sorafenib and Morphine in Rats
por: Karbownik, Agnieszka, et al.
Publicado: (2021) -
The oxidation and hypoglycaemic effect of sorafenib in streptozotocin-induced diabetic rats
por: Karbownik, Agnieszka, et al.
Publicado: (2020) -
Correction to: The oxidation and hypoglycaemic effect of sorafenib in streptozotocin-induced diabetic rats
por: Karbownik, Agnieszka, et al.
Publicado: (2021) -
The Influence of Paracetamol on the Penetration of Sorafenib and Sorafenib N-Oxide Through the Blood–Brain Barrier in Rats
por: Karbownik, Agnieszka, et al.
Publicado: (2020) -
Pharmacokinetic Interaction between Sorafenib and Atorvastatin, and Sorafenib and Metformin in Rats
por: Karbownik, Agnieszka, et al.
Publicado: (2020)